AbstractPathogenicity of influenza B virus was examined in cynomolgus macaques to establish a macaque model suitable for vaccine and antiviral drug development. We prepared influenza B viruses for inoculation with minimal passages after isolation from patients. Macaques inoculated with influenza B virus showed higher body temperature than that before infection for 6 to 12days. Virus was detected in nasal, tracheal, and bronchial samples until 6days after inoculation followed by an increase in neutralizing antibody. High levels of IL-6 and TNF-α in nasal swabs from the infected macaques were correlated with fever. Symptoms and duration of the viral replication would be sufficient to evaluate efficacy of vaccines and antiviral agents. In addi...
Attention has been paid to H5N6 highly pathogenic avian influenza virus (HPAIV) because of its heavy...
The close immunological and physiological resemblance with humans makes non-human primates a valuabl...
Influenza remains a significant global public health burden, despite substantial annual vaccination ...
AbstractPathogenicity of influenza B virus was examined in cynomolgus macaques to establish a macaqu...
Non-human primates are the animals closest to humans for use in influenza A virus challenge studies,...
Non-human primates are the animals closest to humans for use in influenza A virus challenge studies,...
<div><p>Non-human primates are the animals closest to humans for use in influenza A virus challenge ...
Non-human primates are the animals closest to humans for use in influenza A virus challenge studies,...
Pandemic (H1N1) 2009 influenza virus spread throughout the world since most people did not have immu...
Non-human primates are the animals closest to humans for use in influenza A virus challenge studies,...
We examined the pathogenicity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in cyn...
<div><p>The close immunological and physiological resemblance with humans makes non-human primates a...
The close immunological and physiological resemblance with humans makes non-human primates a valuabl...
To control infectious diseases in humans, it is important to understand the pathogenicity of the inf...
<div><p>Pandemic (H1N1) 2009 influenza virus spread throughout the world since most people did not h...
Attention has been paid to H5N6 highly pathogenic avian influenza virus (HPAIV) because of its heavy...
The close immunological and physiological resemblance with humans makes non-human primates a valuabl...
Influenza remains a significant global public health burden, despite substantial annual vaccination ...
AbstractPathogenicity of influenza B virus was examined in cynomolgus macaques to establish a macaqu...
Non-human primates are the animals closest to humans for use in influenza A virus challenge studies,...
Non-human primates are the animals closest to humans for use in influenza A virus challenge studies,...
<div><p>Non-human primates are the animals closest to humans for use in influenza A virus challenge ...
Non-human primates are the animals closest to humans for use in influenza A virus challenge studies,...
Pandemic (H1N1) 2009 influenza virus spread throughout the world since most people did not have immu...
Non-human primates are the animals closest to humans for use in influenza A virus challenge studies,...
We examined the pathogenicity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in cyn...
<div><p>The close immunological and physiological resemblance with humans makes non-human primates a...
The close immunological and physiological resemblance with humans makes non-human primates a valuabl...
To control infectious diseases in humans, it is important to understand the pathogenicity of the inf...
<div><p>Pandemic (H1N1) 2009 influenza virus spread throughout the world since most people did not h...
Attention has been paid to H5N6 highly pathogenic avian influenza virus (HPAIV) because of its heavy...
The close immunological and physiological resemblance with humans makes non-human primates a valuabl...
Influenza remains a significant global public health burden, despite substantial annual vaccination ...